InsiderTrades

Form 4 for GM General Motors

Accepted 2025-08-07 00:00:00 ET · period of report 2025-08-05 · accession 0001467858-25-000126 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-07 2025-08-05 GM Harvey Rory EVP S - Sale+OE $53.01 -24.0K 8,513 -74% -$1.27M
D 2025-08-07 2025-08-05 GM Harvey Rory EVP M - OptEx $41.40 +5,652 14.2K +66% +$234.0K
D 2025-08-07 2025-08-05 GM Harvey Rory EVP M - OptEx $0.00 -5,652 5,652 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-05 S D 11,454 $53.05 15,384 D — — (F1) The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $52.95 to $53.27, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
2 Common Common Stock 2025-08-05 S D 5,652 $53.32 8,513 D — —
3 Common Common Stock 2025-08-05 M A 5,652 $41.40 14,165 D — —
4 Common Common Stock 2025-08-05 S D 6,871 $52.69 8,513 D — — (F2) The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $52.34 to $53.15, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
5 Derivative Employee Stock Option (Right to Buy) 2025-08-05 M D 5,652 $0.00 5,652 D $41.40 · — to 2033-02-07 5,652 Common Stock (F3) These stock options were granted on February 7, 2023, and two-thirds have vested. The remaining installment will vest on February 7, 2026.